Ab­b­Vie makes a hefty play to boost aes­thet­ics busi­ness, pay­ing $550M for non-in­va­sive body sculpt­ing de­vice

When Ab­b­Vie chose to prop up its Al­ler­gan Aes­thet­ics unit as a sep­a­rate busi­ness post-merg­er, it set off some alarm bells that a spin­off or sale could be in the off­ing. But now, Ab­b­Vie is mak­ing an op­por­tunis­tic play to boost the aes­thet­ics busi­ness, adding a long-de­layed body sculpt­ing prod­uct in­to the fold.

Ab­b­Vie’s Al­ler­gan Aes­thet­ics unit will pay $550 mil­lion in cash to scoop up drug­mak­er Soli­ton and Reson­ic, its sound-wave de­vice to im­prove the ap­pear­ance of cel­lulite, the com­pa­ny’s said Mon­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER